16 Figure 3: Risk of OACs in patients on GLP-1s versus patients on insulin Conclusion GLP-1s, initially developed to help manage and treat diabetes and later used to treat obesity, are now showing significant potential to help prevent and treat CVD, mental health disorders, liver and kidney disorders, neurodegenerative disorders, addiction disorders, and cancer
N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken
Nutrients 15, 3585
It also supports molecules like decorin, dermatan sulfate, and chondroitin sulfate, all of which help keep skin hydrated and cushioned from the inside. Newer GHK-Cu Research on Skin Repair In 2023, a study in the Journal of Cosmetic Dermatology tested GHK-Cu alongside hyaluronic acid and found that the two together boosted collagen production more than either could alone. A 2024 review in Applied Sciences highlighted how the peptide supports wound healing, helps new blood vessels form, and brings the right repair cells (macrophages, monocytes, and mast cells) to areas that need healing. A 2025 review published in International Journal of Medical Sciences went even further, looking at next-generation GHK-Cu formulations
BPC-157 and TB-500 are sold and discussed strictly as Research Use Only
In other words, not only might the drug get results like gastric bypass, it could substantially delay orfor people with less advanced arthritispossibly even eliminate the need for pricey and painful knee replacement
